Sean E. Aeder

Array ( [id] => 11075756 [patent_doc_number] => 20160272720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'Compositions and Methods for the Treatment of Acute Myeloid Leukemias and Myelodysplastic Syndromes' [patent_app_type] => utility [patent_app_number] => 15/035217 [patent_app_country] => US [patent_app_date] => 2014-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 26668 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9917150 [patent_doc_number] => 20150072355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'FLAP ENDONUCLEASE-1 AS A MARKER FOR CANCER' [patent_app_type] => utility [patent_app_number] => 14/529702 [patent_app_country] => US [patent_app_date] => 2014-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15403 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14529702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10388017 [patent_doc_number] => 20150273024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'BIOMARKERS FOR H-NOX DELIVERY OF OXYGEN' [patent_app_type] => utility [patent_app_number] => 14/530569 [patent_app_country] => US [patent_app_date] => 2014-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 38691 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14530569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10256583 [patent_doc_number] => 20150141580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'OPTIMIZED DRUG CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/525750 [patent_app_country] => US [patent_app_date] => 2014-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17377 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14525750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11721226 [patent_doc_number] => 09694072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-04 [patent_title] => 'Methods for diagnosing and treating neuroendocrine cancer' [patent_app_type] => utility [patent_app_number] => 14/524483 [patent_app_country] => US [patent_app_date] => 2014-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 13985 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14524483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15574103 [patent_doc_number] => 10577418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Monoclonal anti-GPC-1 antibodies and uses thereof [patent_app_type] => utility [patent_app_number] => 15/520722 [patent_app_country] => US [patent_app_date] => 2014-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20865 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15520722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10240460 [patent_doc_number] => 20150125456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'COLON DISEASE TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/520533 [patent_app_country] => US [patent_app_date] => 2014-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42570 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14520533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367430 [patent_doc_number] => 20150252430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 14/516719 [patent_app_country] => US [patent_app_date] => 2014-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55950 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14516719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11035337 [patent_doc_number] => 20160232293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'DRUG SENSITIVITY BIOMARKERS AND METHODS OF IDENTIFYING AND USING DRUG SENSITIVITY BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 15/029676 [patent_app_country] => US [patent_app_date] => 2014-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30805 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12143812 [patent_doc_number] => 09878049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-30 [patent_title] => 'High drug loading system to co-deliver anticancer drugs and nucleic acids for cancer therapy' [patent_app_type] => utility [patent_app_number] => 14/510442 [patent_app_country] => US [patent_app_date] => 2014-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 10 [patent_no_of_words] => 5189 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14510442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9812475 [patent_doc_number] => 20150024420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'EXTRACELLULAR AND MEMBRANE-ASSOCIATED PROSTATE CANCER MARKERS' [patent_app_type] => utility [patent_app_number] => 14/508764 [patent_app_country] => US [patent_app_date] => 2014-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9636 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14508764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11054479 [patent_doc_number] => 20160251440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'BISPECIFIC NANOBODIES' [patent_app_type] => utility [patent_app_number] => 15/024993 [patent_app_country] => US [patent_app_date] => 2014-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 46368 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11763208 [patent_doc_number] => 09371570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-21 [patent_title] => 'Mutant calreticulin for the diagnosis of myeloid malignancies' [patent_app_type] => utility [patent_app_number] => 14/486973 [patent_app_country] => US [patent_app_date] => 2014-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 90418 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10201565 [patent_doc_number] => 20150086553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'POLYPEPTIDE BINDING TO ANNEXIN A1 AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/482959 [patent_app_country] => US [patent_app_date] => 2014-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14347 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14482959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11229831 [patent_doc_number] => 09457043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Combination therapy using c-Met inhibitor and c-Myc inhibitor' [patent_app_type] => utility [patent_app_number] => 14/481509 [patent_app_country] => US [patent_app_date] => 2014-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 14242 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14481509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9916725 [patent_doc_number] => 20150071930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'COMBINATION THERAPY USING C-MET INHIBITOR AND BETA-CATENIN INHIBITOR' [patent_app_type] => utility [patent_app_number] => 14/480174 [patent_app_country] => US [patent_app_date] => 2014-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16619 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14480174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10289277 [patent_doc_number] => 20150174274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'MODULATION OF IMMUNITY AND CEACAM1 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/467619 [patent_app_country] => US [patent_app_date] => 2014-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 42153 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14467619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895075 [patent_doc_number] => 20150050274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'METHODS AND BIOMARKERS FOR DETECTION AND TREATMENT OF MATURE T-CELL LEUKEMIA' [patent_app_type] => utility [patent_app_number] => 14/459928 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 27409 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10234294 [patent_doc_number] => 20150119288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'KITS FOR MULTIPARAMETRIC PHOSPHO ANALYSIS' [patent_app_type] => utility [patent_app_number] => 14/450639 [patent_app_country] => US [patent_app_date] => 2014-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33168 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14450639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10960800 [patent_doc_number] => 20140363831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'COMPOUNDS AND METHODS USEFUL FOR DETECTION AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/340467 [patent_app_country] => US [patent_app_date] => 2014-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17053 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14340467 [rel_patent_id] =>[rel_patent_doc_number] =>)